Digital pathology solutions are approaching a tipping point in the market, despite only 17 % of our survey respondents digitizing slides for clinical diagnosis. Read our new market report to learn more.
Discover how NanoZoomers could be integrated into your workflow for optimal efficiencies.
NanoZoomer product range and its possibility
Important Notice:
Following products are CE marked under EU’s In Vitro Diagnostics Directive (IVDD) for in vitro diagnostic use:
NanoZoomer S360, NanoZoomer S210, NanoZoomer S60, NanoZoomer-SQ including optional software e.g. NDP.view2 (U12388-21), NDP.view2 plus (U12388-22) and NDP.serve3 software (U13173-21, -22, -23).
In China, following products are registered for in vitro diagnostic use:
NanoZoomer S360, NanoZoomer S210, NanoZoomer S60 and NanoZoomer-SQ.
In Canada, NanoZoomer S360 (C13220-31) has Medical Device License (License No. 97957).
In Russia, following products are registered as medical device:
NanoZoomer S360, NanoZoomer S210, NanoZoomer S60 and NanoZoomer-SQ.
In Israel, following products are registered as medical device:
NanoZoomer S360, NanoZoomer S210, NanoZoomer S60 and NanoZoomer-SQ.
In the US, Japan and other countries, NanoZoomer is for research use only and is not permitted to use for clinical diagnostic purposes.
